Framework logo

Framework Review

6.6
★★★☆☆3.3/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10

Best for: aggressive $25/week pricing with a named 503B pharmacy partner

Price is where Framework scores best in our breakdown.

Semaglutide

$108/mo · “starting at” price

Tirzepatide

$108/mo · “starting at” price

Price checked on Framework’s site,

What the monthly price covers

Medication

Included

Provider visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Included

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Framework is a personalized-plan GLP-1 telehealth platform offering compounded semaglutide and tirzepatide with doctor-guided treatment selection. It names its pharmacy partner, The Pharmacy Hub, which operates on the FDA-registered 503B outsourcing pathway rather than the patient-specific 503A compounding most direct-to-consumer competitors use. Pricing starts as low as $25/week (roughly $100/mo) with no membership fees.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatide503A PharmacyUS-licensed clinicians

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Framework

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Framework logo
3.3 / 5
Our editorial rating
Visit Framework →

from $108/mo (“starting at” price) · no insurance needed

Framework at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$108/mo (“starting at” price)
What's included
Medication · Coaching
FDA status
No FDA warning letter on record

How we scored Framework

Each dimension is scored algorithmically from Framework’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.6/10

At $108/mo (“starting at” price), Framework runs about 39% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).

Effectiveness25%

7.1/10

Framework offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

5.9/10

Online intake and platform experience; 5 platform features disclosed.

Trust & Safety15%

6.3/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

5.1/10

Framework's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

6.2/10

Coaching/dietitian access included.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Framework review

Last checked November 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$108/mo across 2 dose/plan tiers (checked November 2026)
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Framework

We walked Framework’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Start an online visit, described as taking less than 3 minutes.
  2. 2Provide your medical information through the intake portal.
  3. 3A licensed provider reviews your information and prescribes compounded GLP-1 if appropriate.
  4. 4If prescribed, your compounded semaglutide or tirzepatide is dispensed.
Price shown before you start
  • Offers compounded semaglutide and tirzepatide.
  • Advertises 'GLP-1s for as low as $25/week' and '$0 membership fees' up front, before intake.
  • Signup is positioned as fast ('less than 3 minutes').
  • Homepage carries a disclaimer that its compounded medications are not FDA-approved and are not substitutes for FDA-approved medications.
  • Refund/cancellation, shipping, and lab details are not stated on the homepage.

Framework customer support

GLP-1 medications Framework offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

As low as $25/week (~$100/mo)Compounded
$108.33/mo
semaglutide

Framework prices per week ('GLP 1s For As Low as $25/Week'). Fifty-two weeks is $1,300 a year, so a calendar month works out to $108.33 rather than $100. It also advertises '$0 membership fees.'

As low as $25/week (~$100/mo)Compounded
$108.33/mo
tirzepatide

Same per-week rate; Framework quotes one figure for semaglutide and tirzepatide alike.

Ready to get started?

Plans and promotions change often, so check Framework's current pricing and active discounts before you decide.

See Framework pricing →

What we like

  • Names its 503B pharmacy partner, The Pharmacy Hub (an FDA-registered outsourcing facility, distinct from 503A)
  • Publishes the FDA compounded-medication disclaimer
  • $25/week pricing (~$100/mo) is among the most aggressive in the directory
  • $0 membership fees
  • Phone support published, toll-free (888) 412-0666
  • Personalized plans rather than a one-size-fits-all marketplace

Watch-outs

  • LegitScript ID / certification not shown on the homepage
  • States-served list not disclosed
  • Medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed (no footer copyright)
  • Governing law / arbitration venue not stated
  • Refund / cancellation policy not detailed
  • Per-dose pricing tiers not shown (only the 'as low as $25/week' starting tier)

Framework: the rare telehealth brand that names its 503B pharmacy

Most direct-to-consumer GLP-1 startups keep their pharmacy a secret and lean on a low headline number to win you over. Framework does the cheap-number thing too. It advertises compounded semaglutide and tirzepatide for as little as a quarter of a hundred dollars a week, which works out to roughly $108.33 a month (“starting at” price) with no membership fee on top. What is unusual is that it tells you who makes the medicine: The Pharmacy Hub, an FDA-registered 503B outsourcing facility. Few rivals disclose that much.

Why the 503B detail matters to you

Compounded GLP-1s can be made two ways. The common one for telehealth is 503A: a pharmacy mixing a batch for a specific named patient, with lighter federal oversight. The other is 503B, an outsourcing facility that registers with the FDA, gets inspected like a manufacturer, and follows stricter quality-control rules. Framework says its partner, The Pharmacy Hub, runs on the 503B pathway. In plain terms: the place making your shots is held to a higher manufacturing standard than the patient-by-patient model most competitors use. Framework is one of the only providers on this site that both names the pharmacy and points to that registration. For a product where you're injecting yourself weekly, knowing the source is not a small thing.

How the pricing works

Framework's pitch is one clear price with zero membership fees, and the medication is included in what you pay. The advertised rate is a starting tier, as the "as low as" wording signals. The site shows the entry price of about $108.33 a month (“starting at” price) but does not publish a full per-dose ladder, so what you pay as your dose climbs over the months isn't spelled out up front. That's normal for compounded programs (higher doses usually cost more), but it means the headline isn't a guaranteed flat rate. Even so, the entry point is aggressive: it sits well below our category median of $179 a month, and because there's no separate membership charge, you're not stacking a recurring fee on top of the drug.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

  • What's included: the compounded medication itself, plus dietitian support and clinician check-ins
  • Membership fee: none, which saves money versus programs that bill a monthly platform charge on top of the drug
  • Dose pricing: only the starting tier is published, so confirm your price at the dose you'll be taking before you commit

The medications and how you get them

You're choosing between compounded semaglutide (the molecule in Ozempic and Wegovy) and compounded tirzepatide (the one in Mounjaro and Zepbound). These are compounded versions, not brand-name pens, and Framework is upfront about what that means. The site publishes the full FDA disclaimer in plain sight: these formulations aren't FDA-approved and haven't been through clinical trials for safety, efficacy, or equivalence to the approved drugs. Framework says U.S.-licensed clinicians guide the selection between the two drugs rather than letting you just pick off a menu, which fits its "personalized plan" positioning.

What Framework doesn't tell you

Framework also leaves several blanks. The homepage doesn't show a LegitScript certification, which is the badge serious telehealth pharmacies usually display. It doesn't list which states it serves, so you can't confirm coverage where you live without contacting them. There's no named medical director or clinical leadership, no corporate legal entity in the footer (no LLC or Inc. to identify who you're doing business with), and no published refund, cancellation, or arbitration terms. None of these are deal-breakers on their own, but together they lower Framework's score. The pharmacy disclosure is strong; the corporate and regulatory transparency around it is thin. Shoppers who want a practice they can locate can compare Alegro Health, a McKinney, Texas clinic with a published address and hours, but it offers only semaglutide and doesn't list the states it serves.

Who should choose Framework, and who shouldn't

Framework is a good fit if your priority is a low monthly cost from a provider that's willing to name its pharmacy and point to a higher-grade 503B manufacturing pathway. If you've been comparing programs and you care more about where the medicine comes from than about brand-name pens, this is one of the cheaper credible options to look at.

Skip it if you need certainty before you sign up. If you want to confirm your state is covered, see a published refund policy, know the name of the medical director overseeing your care, or get an exact price for the higher dose you'll eventually reach, Framework doesn't put those answers on the page. When a set dose price and written refund terms are your priorities, Factor Health MD charges one flat rate at every dose and publishes its refund agreement, but its weight-loss plans carry a three-month commitment. Anyone who wants brand-name Wegovy or Zepbound should also look elsewhere, since this is a compounded-only program.

Getting your questions answered

Framework publishes a toll-free phone line, (888) 412-0666, plus an email at support@yourframework.com. Before you pay, use the phone number to confirm three things the site leaves out: whether they ship to your state, what the price becomes at higher doses, and what happens if you want to cancel. A provider that answers those clearly over the phone earns a lot more trust than the homepage alone gives.

Bottom line

Framework does well on two things that are hard to fake: a named, FDA-registered 503B pharmacy partner and a visible FDA disclaimer, paired with a low $108.33 (“starting at” price)-a-month starting price and no membership fee. Both strengths can be checked. The weakness is everything around them: no disclosed states, no LegitScript, no named clinical leadership, no corporate entity, no posted refund terms. If transparency about the pharmacy is what you weight most, Framework is one of the better-value picks on this site. If you need the full paperwork before trusting a telehealth brand, call them first and get the gaps filled in before you commit. You can see how we weigh these signals in our scoring methodology.

The Bottom Line

Price is where Framework scores best in our breakdown.

Score: 6.6/10Best for: aggressive $25/week pricing with a named 503B pharmacy partnerFrom: $108/mo (“starting at” price)

Ready to start with Framework?

From $108/mo (“starting at” price). See current pricing and start your free consultation.

Framework might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).

Head-to-head

Compare Framework vs…

Framework scores6.6/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Framework is a personalized-plan GLP-1 telehealth platform offering compounded semaglutide and tirzepatide with doctor-guided treatment selection. It names its pharmacy partner, The Pharmacy Hub, which operates on the FDA-registered 503B outsourcing pathway.
Framework advertises GLP-1 medications for as low as $25/week (roughly $100/month) with $0 membership fees. Per-dose pricing tiers beyond the starting rate are not published on the site.
Framework says plans include dietitian support, personalized plans, and clinician check-ins under one clear price with no membership fee. A licensed clinician guides medication selection based on your health.
Framework offers compounded semaglutide and tirzepatide, and it publishes the disclaimer that these formulations are not FDA-approved and have not undergone clinical trials evaluating their safety, efficacy, or equivalence to approved medications. A licensed clinician determines whether treatment is appropriate for you.
Framework names The Pharmacy Hub, an FDA-registered 503B outsourcing facility, rather than the patient-specific 503A compounding most direct-to-consumer competitors use, which is a more transparent disclosure. Note that 503B compounded products are still not FDA-approved finished drugs.
Framework does not show a LegitScript ID, publish a states-served list, name a medical director, or disclose its corporate legal entity or refund policy, which keeps our confidence at medium. Its aggressive $25/week pricing and named 503B partner are its strongest points.
Framework doesn't use public promo or coupon codes. Third-party sites advertising "Framework discount codes" are typically fake; any current offer applies automatically through the link on this page.
Framework is an operating telehealth provider, and we found no FDA warning letter on file for it. We could not confirm a LegitScript certification from its public pages. We last checked its prices and policies on its own site in November 2026. We scored it 6.6/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Framework. The concerns our review flags: LegitScript ID / certification not shown on the homepage; States-served list not disclosed; Medical director / clinical leadership not disclosed; Corporate legal entity not disclosed (no footer copyright). Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Framework review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Framework's current pricing

Plans from $108/mo (“starting at” price). Start your free consultation to check eligibility and today's price.